Food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels

Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...
Healio

GLP-1s may lower risk for all-cause mortality, hospitalization in type 1 diabetes

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...
STAT

Pharmalittle: We’re reading about a change in obesity drug warnings, FDA approvals, and more

After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely ...

Sales of a powerful Nvidia AI chip to China gets the greenlight, with conditions

The Trump administration placed new security requirements on Nividia's semiconductor sales to China, but essentially ...
The Malaysian Reserve

Shed Expands GLP-1 Weight-Loss Offerings with Wegovy® Pills via NovoCare

Through Shed’s GLP-1 Weight-Loss Programs, eligible members can now access Wegovy® in both oral and injectable formats, backed by ongoing support and personalized care. In addition to Wegovy®, Shed ...
BioSpace

JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New Era

BMO analysts say Eli Lilly is well-positioned to maintain its lead in the ballooning weight loss space, predicting “strengthening leadership in obesity and beyond” as portfolios expand and patient ...